Repligen Corporation (RGEN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Repligen Corporation, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Repligen Corporation (RGEN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $8.6B. It trades at $184.69, up 5.06% today. 7 analysts' average target of $207.83 implies +12.5% from today's price. Kronos AI's 30-day forecast is −12.9% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $207.83 |
| Low – high | $180.00 – $235.00 |
| Analysts | 7 |
| Upside to average | +12.5% |
Kronos AI 30-day forecast
| Expected close | $153.12 (−12.9%) |
| Likely range | −15.0% … −0.4% |
| As of | 2026-10-27 |
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator